LEXAPRO BIRTH DEFECT INJURY ATTORNEY
Birth Defect Attorney
Lexapro is in the selective serotonin reuptake inhibitor (SSRI) class of antidepressants. Lexapro, like Celexa, is manufactured and marketed in the United States by Forest Laboratories.
Lexapro and Celexa are in the same class of drugs as other SSRIs and SNRIs such as Prozac, Zoloft, Paxil, Wellbutrin, Pristiq and Effexor, which have been be linked to increased risks of birth defects in children who are exposed to the drugs in utero.
TYPES OF LEXAPRO BIRTH DEFECT INJURIES
Based on the medical literature and opinions of experts in the field, Lexapro and Celexa can be linked to the following types of birth defects:
- Anal Atresia (complete or partial closure of the anus)
- Autism or Autism Spectrum Disorder
- Cardiac defects or heart defects
- Cleft lip or cleft palate
- Club foot or bilateral club foot (one or both feet turn downward and inward)
- Craniosynostosis (skull defects)
- Limb defects or limb reductions
- Neural-tube defects (spina bifida, anencephaly, and other brain and spinal cord birth defects)
- Omphalocele (stomach defect where organs develop outside the stomach wall)
- PPHN (Persistent Pulmonary Hypertension of the Newborn)
LEXAPRO BIRTH DEFECT WARNING
Like Celexa, Paxil, Prozac, and Zoloft, Lexapro is an SSRI. Evidence of Paxil’s link to an increased risk of cardiac defects and birth defects was revealed in September 2005. ( read warning here )
Thereafter, in early 2006, the New England Journal of Medicine released an abstract article which reported a six (6)-fold increased risk of Persistent Pulmonary Hypertension of a Newborn (PPHN) in children exposed to SSRIs, like Lexapro, in utero. ( read article here )
Following the New England Journal of Medicine abstract in early 2006, the FDA released the Public Heath Advisory: Treatment Challenges of Depression in Pregnancy and the Possibility of Persistent Pulmonary Hypertension in Newborns on July 19, 2006. ( read advisory here )
THE FDA DOES NOT TEST DRUGS
Although surprising to many mothers, the FDA does not do its own drug research. Rather, it is the pharmaceutical companies’ responsibility to research the safety of their drugs. Unfortunately, the warnings in 2005 and 2006 came more than ten years after most SSRIs and SNRIs were first released on the market. As a result, many children were born with antidepressant birth defects.
CONTACT A LEXAPRO BIRTH DEFECT LAWYER
A birth defect injury attorney can help you decide whether you qualify for financial compensation. If you took Lexapro or Celexa during pregnancy and your child was born with one of the above-mentioned birth defects, contact The Dwyer Law Firm today to determine what the best course of action is for you and your family.